Filter News
Area of Research
- Biology and Environment (29)
- Biology and Soft Matter (1)
- Computational Biology (1)
- Electricity and Smart Grid (1)
- Energy Science (40)
- Functional Materials for Energy (1)
- Fusion and Fission (2)
- Materials (10)
- Materials for Computing (3)
- National Security (3)
- Neutron Science (12)
- Nuclear Science and Technology (2)
- Supercomputing (17)
- Transportation Systems (1)
News Topics
- (-) Coronavirus (48)
- 3-D Printing/Advanced Manufacturing (144)
- Advanced Reactors (40)
- Artificial Intelligence (125)
- Big Data (77)
- Bioenergy (110)
- Biology (126)
- Biomedical (73)
- Biotechnology (37)
- Buildings (73)
- Chemical Sciences (84)
- Clean Water (32)
- Composites (34)
- Computer Science (223)
- Critical Materials (29)
- Cybersecurity (35)
- Education (5)
- Element Discovery (1)
- Emergency (4)
- Energy Storage (114)
- Environment (217)
- Exascale Computing (64)
- Fossil Energy (8)
- Frontier (62)
- Fusion (65)
- Grid (74)
- High-Performance Computing (128)
- Hydropower (12)
- Irradiation (3)
- Isotopes (62)
- ITER (9)
- Machine Learning (67)
- Materials (156)
- Materials Science (156)
- Mathematics (12)
- Mercury (12)
- Microelectronics (4)
- Microscopy (56)
- Molten Salt (10)
- Nanotechnology (63)
- National Security (86)
- Neutron Science (169)
- Nuclear Energy (121)
- Partnerships (66)
- Physics (68)
- Polymers (35)
- Quantum Computing (52)
- Quantum Science (88)
- Security (30)
- Simulation (64)
- Software (1)
- Space Exploration (26)
- Statistics (4)
- Summit (70)
- Transportation (102)
ORNL's Communications team works with news media seeking information about the laboratory. Media may use the resources listed below or send questions to news@ornl.gov.
91 - 100 of 130 Results

Energy Secretary Jennifer Granholm visited ORNL on Nov. 22 for a two-hour tour, meeting top scientists and engineers as they highlighted projects and world-leading capabilities that address some of the country’s most complex research and technical challenges.

Research teams from the Department of Energy’s Oak Ridge National Laboratory and their technologies have received seven 2021 R&D 100 Awards, plus special recognition for a COVID-19-related project.

Oak Ridge National Laboratory researchers developed and demonstrated algorithm-based controls for a hybrid electric bus that yielded up to 30% energy savings compared with existing controls.

Nearly a billion acres of land in the United States is dedicated to agriculture, producing more than a trillion dollars of food products to feed the country and the world. Those same agricultural processes, however, also produced an estimated 700 million metric tons of carbon dioxide equivalent in 2018, according to the U.S. Department of Agriculture.

As the United States transitions to clean energy, the country has an ambitious goal: cut carbon dioxide emissions in half by the year 2030, if not before. One of the solutions to help meet this challenge is found at ORNL as part of the Better Plants Program.

An ORNL-led team comprising researchers from multiple DOE national laboratories is using artificial intelligence and computational screening techniques – in combination with experimental validation – to identify and design five promising drug therapy approaches to target the SARS-CoV-2 virus.

Scientists at ORNL have discovered a single gene that simultaneously boosts plant growth and tolerance for stresses such as drought and salt, all while tackling the root cause of climate change by enabling plants to pull more carbon dioxide from the atmosphere.

When COVID-19 was declared a pandemic in March 2020, Oak Ridge National Laboratory’s Parans Paranthaman suddenly found himself working from home like millions of others.

When Kashif Nawaz looks at a satellite map of the U.S., he sees millions of buildings that could hold a potential solution for the capture of carbon dioxide, a plentiful gas that can be harmful when excessive amounts are released into the atmosphere, raising the Earth’s temperature.

Scientists have found new, unexpected behaviors when SARS-CoV-2 – the virus that causes COVID-19 – encounters drugs known as inhibitors, which bind to certain components of the virus and block its ability to reproduce.